Protease inhibitors and carcinogenesis: A review

Cancer Investigation

Volumn 14, Issue 6, 1996, Pages 597-608

  Clawson, Gary A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE DERIVATIVE; PHYTIC ACID; PHYTOSTEROL; PROTEINASE INHIBITOR; SAPONIN DERIVATIVE;

CANCER INHIBITION; CARCINOGENESIS; CHEMOPROPHYLAXIS; DIET; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0030473568     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609076904     Document Type: Review

References (114)

1. Troll W, Frenkel K, Wiesner R: Protease inhibitors as anticarcinogens. J Natl Cancer Inst 73:1245-1250, 1984.
2. Kennedy A: Prevention of carcinogenesis by protease inhibitors. Cancer Res 54:1999s-2005s, 1994.
3. Block G, Patterson B, Subar A: Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18:1-29, 1992.
4. Goldbohm R, Van den Brandt P, van't Veer P, et al: A prospective cohort study on the relation between meat consumption and the risk of colon cancer. Cancer Res 54:718-723, 1994.
5. Willett W, Stampfer M, Colditz G, Rosner B, Hennekens C, Speizer F: Dietary fat and the risk of breast cancer. N Engl J Med 316:22-28, 1987.
6. Enstrom J: Reassessment of the role of dietary fat in cancer etiology. Cancer Res 41:3722-3723, 1981.
7. Hirayama T: Relationship of soybean paste soup intake to gastric cancer risk. Nutr Cancer 3:223-233, 1982.
8. Birk Y: The Bowman-Birk inhibitor: Trypsin- and chymotrypsin-inhibitor from soybeans. Int J Peptide Prot Res 25:113-131, 1985.
9. Eldridge A, Kwolek W: Soybean isoflavones: Effect of environment and variety on composition. J Agr Food Chem 31:394-396, 1983.
10. Messina M, Barnes S: Commentary. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 83:541-546, 1991.
11. Calam J, Bojarski J, Springer C: Raw soya-bean flour increases cholecystokinin release in man. Br J Nutr 58:175-179, 1987.
12. Troll W, Weisner R, Frenkel K: Anticarcinogenic action of protease inhibitors. Adv Cancer Res 49:265-283, 1987.
13. Barnes S, Grubbs C, Setchell K, Carlson J: Soybeans inhibit mammary tumors in models of breast cancer. In: Mutagens and Carcinogens in the Diet, edited by M Pariza. New York, Wiley-Liss, 1990, pp 239-253.
14. Yavelow J, Finlay T, Kennedy A, Troll W: Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res 43:2454s-2459s, 1983.
15. Madar Z, Gertler A, Birk Y: The fate of the Bowman Birk trypsin inhibitor from soybeans in the digestive tract. Comp Biochem Physiol 62A:1057-1061, 1979.
16. Axelson M, Sjovall J, Gustafsson B, et al: Soya - A dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 102:49-56, 1984.
17. Barbuch R, Coutant J, Welsh M, et al: The use of thermospray liquid chromatography/tandem mass spectrometry for the class identification and structural verification of phytoestrogens in soy protein preparations. Biomed Environ Mass Spectrom 18:973-977, 1989.
18. Martin P, Horowitz K, Ryan D, McGuire W: Phytoestrogen interaction with estrogen receptors in human breast cells. Endocrinology 103:1860-1867, 1978.
19. Mathieson R, Kills W: Binding of phytoestrogens and estradiol 17b by cytoplasmic receptors in the pituitary gland and the hypothalamus of the ewe. J Endocrinol 85:317-325, 1980.
20. Akiyama T, Ishida J, Nakagawa S, et al: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595, 1987.
21. Weihrauch J, Gardner J: Sterol content of foods of plant origin. J Am Diet Assoc 73:39-47, 1978.
22. Oakenfull D: Saponins in food - A review. Food Chem 6:19-40, 1981.
23. Raicht R, Cohen B, Fazzini E, et al: Protective effect of plant sterols against chemically induced colon tumors in rats. Cancer Res 40:403-405, 1980.
24. Deschner E, Cohen B, Raicht R: The kinetics of the protective effect of b-sitosterol against MNU-induced colonic neoplasia. J Cancer Res Clin Oncol 103:49-54, 1982.
25. Graf E, Eaton J: Dietary suppression of colonic cancer: Fiber or phytate? Cancer 56:717-718, 1985.
26. Shamsuddin A, Ullah A, Chakravarthy A: Inositol and inositol hexaphosphate suppresses cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 10:1461-1463, 1989.
27. Graf E, Eaton J: Antioxidant functions of phytic acid. Free Radic Biol Med 8:61-69, 1990.
28. Graf J, Mahoney J, Bryant R, et al: Iron-catalyzed hydroxyl formation. J Biol Chem 259:3620-3624, 1984.
29. Birt D, Bresnick E: Chemoprevention by nonnutrient components of vegetables and fruits. In: Human Nutrition: A Comprehensive Treatise. New York, Plenum Press, 1990.
30. Wei H, Tye L, Bresnick E, Birt D: Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50:499-502, 1990.
31. Osawa T, Kumon H, Namiki M, Kawakishi S, Fukuda Y: Antimutagenic heat stable antioxidants. In: Mutagens and Carcinogens in the Diet, edited by M Pariza, J Felton, H Aeschbacher, S. Sato. New York, Wiley-Liss, 1990, pp 223-238.
32. Crowell P, Gould M: Chemoprevention and therapy of cancer by D-limonene. Crit Rev Oncogenesis 5:1-22, 1994.
33. Crowell P, Ren Z, Lin S, Vedejs E, Gould M: Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharm 47:1405-1415, 1994.
34. Raiten D, Titus E: Evaluation of Evidence for the Carcinogenicity of Butylated Hydroxyanisole (BHA). Bethesda, MD, Life Sciences Research Office, FASEB, 1994.
35. Boutwell R: Opportunities for nutritional scientists in cancer prevention. In: Mutagens and Carcinogens in the Diet, edited by M Pariza, J Felton, H Aeschbacher, S Sato. New York, Wiley-Liss, 1990, pp 269-284.
36. Ip C, Carter C, Ip M: Requirement of essential fatty acid for mammary tumorigenesis. Cancer Res 45:1997-2001, 1985.
37. Pariza M, Ha Y: Conjugated dienoic derivatives of linoleic acid Mechanism of anticarcinogenic effect. In: Mutagens and Carcinogens in the Diet, edited by M Pariza, J Felton, H Aeschbacher, S Sato. New York, Wiley-Liss, 1990, pp 217-222.
38. Billings P, Brandon D, Habres J: Internalization of the Bowman-Birk protease inhibitor by intestinal epithelial cells. Eur J Cancer 27:903-908, 1991.
39. Yavelow J, Scott C, Mayer T: Fluorescent visualization of binding and internalization of the anticarcinogenic Bowman-Birk type protease inhibitors in transformed fibroblasts. Cancer Res 47:1602-1607, 1987.
40. Schelp F, Pongpaew P: Protection against cancer through nutritionally-induced increase of endogenous proteinase inhibitors - An hypothesis. Int J Epidemiol 17:287-292, 1988.
41. Billings P, St. Clair W, Ryan C, Kennedy A: Inhibition of radiation-induced transformation of C3H/10T1/2 cells by chymotrypsin inhibitor 1 from potatoes. Carcinogenesis 8:809-812, 1987.
42. Gertler A, Poraz I, Cohen N, Gottesfeld F: Inhibition of human and dog serine pancreatic proteinases by naturally occurring high-molecular-weight inhibitors from plant or animal origin. Biochem Med 27:143-153, 1982.
43. Gurusiddaiah S, Kuo T, Ryan C: Immunological comparisons of chymotrypsin inhibitor 1 among several genera of the Solanaceae. Plant Phys 50:627-631, 1972.
44. Plunkett G, Senear D, Zuroske G, Ryan C: Proteinase inhibitors 1 and II from leaves of wounded tomato plants: Purification and properties. Arch Biochem Biophys 213:463-472, 1982.
45. Kuo T, Pearce G, Ryan C: Isolation and characterization of proteinase inhibitor 1 from etiolated tobacco leaves. Arch Biochem Biophys 230:504-510, 1984.
46. Liener I, Goodale R, Deshmukh A, et al: Effect of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas. 1988.
47. Liddle R, Goldfine I, Williams J: Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin inhibitor, and alcohol. Gastroenterology 87:542-549, 1984.
48. Nitsan Z, Liener I: Enzymic activities in the pancreas, digestive tract, and feces of rats fed raw or heated soy flour. J Nutr 106:300-305, 1976.
49. Howatson A: The potential of cholecystokinin as a cocarcinogen in the hamster-nitrosamine model. In: Nutritional and Toxicological Significance of Enzyme Inhibitors in Foods, edited by M Friedman. New York, Plenum Press, 1986, pp 109-121.
50. Roebuck B: Enhancement of pancreatic carcinogenesis by raw soy protein isolate. Quantitative rat model and nutritional considerations. In: Nutritional and Toxicological Significance of Enzyme Inhibitors in Foods, edited by M Friedman. New York, Plenum Press, 1986, pp 91-108.
51. Troll W, Klassen A, Janoff A: Tumorigenesis in mouse skin: Inhibition by synthetic inhibitors of proteases. Science 169:1211-1213, 1970.
52. Schiessler H, Ohlsson K, Olsson I, Arnhold M, Birk Y, Fritz H: Elastases from human and canine granulocytes. H. Interaction with protease inhibitors of animal, plant, and microbial origin. Hoppe-Seyler Z Physiol Chem 358:53-58, 1977.
53. Hojima Y, Pisano J, Cochrane C: Survey of plant inhibitors of polymorphonuclear leukocyte elastase, pancreatic elastase, cathepsin G, cathepsin B, hageman factor fragments, and other serine proteinases. Biochem Pharm 32:985-990, 1983.
54. Hozumi M, Ogawa M, Sugimura T, Takeuchi T, Umezawa H: Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes. Cancer Res 32:1725-1728, 1972.
55. Fischer S, Mills G, Slaga T: Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis 3:1243-1245, 1982.
56. Verma A, Garcia C, Ashendel C, Boutwell R: Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Cancer Res 43: 3045-3049, 1983.
57. Aldaz C, Conti C, Gimenez I, Slaga T, Klein-Szanto A: Cutaneous changes during prolonged application of 12-0-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res 45:2753-2759, 1985.
58. Troll W: Prevention of cancer by agents that suppress oxygen radical formation. Free Rad Res Commun 12-13:751-757, 1991.
59. Goldstein B, Witz G, Amoruso M, Troll W: Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption. Biochem Biophys Res Commun 88:854-860, 1979.
60. Zacharski L, Meehan K, Algarra S, Calvo F: Clinical trials with anticoagulant and antiplatelet therapies. Cancer Metast Rev 11:421-431, 1992.
61. Burger M: Proteolytic enzymes initiating cell division and escape from contact inhibition of growth. Nature 227:170-171, 1970.
62. Cunningham D, Ho T: Effects of added proteases on concanavalin A-specific agglutinability and proliferation of quiescent fibroblasts. In: Proteases and Biological Control, edited by E Reich, D Rifkin, E Shaw. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory, 1975, pp 795-806.
63. Schnebli H, Burger M: Selective inhibition of growth of transformed cells by protease inhibitors. Proc Natl Acad Sci USA 69:3825-3827, 1972.
64. Clawson G, Ren L, Isom H: Nuclear scaffold protease: In situ nuclear localization and effects of a protease inhibitor on growth and morphology of ras-transformed hepatocytes. Hepatology 22:1230-1235, 1995.
65. Kuroki T, Drevon C: Inhibition of chemical transformation in C3H/10T1/2 cells by protease inhibitors. Cancer Res 39:2755-2761, 1979.
66. Kennedy A, Little J: Protease inhibitors suppress radiation induced malignant transformation in vitro. Nature 276:825-826, 1978.
67. Kennedy A, Little J: Effects of protease inhibitors on radiation transformation in vitro. Cancer Res 41:2103-2108, 1981.
68. Garte S, Currie D, Troll W: Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors. Cancer Res 47:3159-3162, 1989.
69. Clawson G, Norbeck L, Wise J, Patierno S: An inhibitor of nuclear scaffold protease blocks chemical transformation of fibroblasts. Cell Growth Diff 4:589-594, 1993.
70. Ku G, Quigley J, Sultzer B: The inhibition of the mitogenic stimulation of B lymphocytes by a serine protease inhibitor: Commitment to proliferation correlates with an enhanced expression of a cell-associated arginine-specific serine enzyme. J Immunol 131:2494-2499, 1983.
71. 2+ and IL-2 production in activated jurkat T cells. J Immunol 142:1253-1259, 1989.
72. Sugatani J, Miwa M, Hanahan D: Platelet-activating factor stimulation of rabbit platelets is blocked by serine protease inhibitor (chymotryptic protease inhibitor). J Biol Chem 262:5740-5747, 1987.
73. O'Donnell-Tormey J, Quigley J: Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts. Proc Natl Acad Sci USA 80:344-348, 1983.
74. Jakobs K, Aktories K: Stimulation of high-affinity GTPase by trypsin and trypsin-like proteinases in membranes of human platelets. Biochem J 249:639-643, 1988.
75. Ponzio G, Contreres J, Debant A, Auberger P, Farahifar D, Rossi B: Inhibitors of chymotrypsin-like activities selectively block the mitotic pathway in rat hepatoma cells. Growth Factors 4:37-44, 1990.
76. Clawson G, Noroeck L, Hatem C, et al: Ca2+-regulated serine protease associated with the nuclear scaffold Cell Growth Diff 3:827-838, 1992.
77. Chang J, Li J, Billings P, Kennedy A: Effects of protease inhibitors on c-myc expression in normal and transformed C3H10T1/2 cells. Mol Carcinogen 3:226-232, 1990.
78. Caggana M, Kennedy A: C-fos mRNA levels are reduced in the presence of antipain and the Bowman-Birk inhibitor. Carcinogenesis 10:2145-2148, 1989.
79. Cox L, Motz J, Troll W, Garte S: Antipain-induced suppression of oncogene expression in H-ras-transformed NIH3T3 cells. Cancer Res 51:4810-4814, 1991.
80. Brown R, Clark R, Chiu J, Stubblefield E: Protease activation of GI nuclei isolated from Chinese hamster fibroblasts. Exp Cell Res 104:207-213, 1977.
81. Wintersberger U: The selective advantage of cancer cells: A consequence of genome mobilization in the course of the induction of DNA repair processes? (Model studies on yeast). Adv Enzyme Reg 22:311-322, 1984.
82. Fornace A: Mammalian genes induced by radiation: Activation of genes associated with growth control. Annu Rev Genet 26:507-526, 1992.
83. Smith M, Chen I, Zhan Q, et al: Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266:1376-1380, 1994.
84. Livingstone L, White A, Sprouse J, Livanos E, Jacks T, Tlsty T: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935, 1992.
85. Little J, Mount D: The SOS regulatory system of Escherichia coli. Cell 29:11-22, 1982.
86. Kadhim M, Macdonald D, Goodhead D, Lorimore S, Marsden S, Wright E: Transmission of chromosomal instability after plutonium α-particle irradiation. Nature 355:738-740, 1992.
87. Gaziev A, Kutsy M: Gamma-irradiated DNA activates histone H1-specific proteinase of rat liver nuclei. Int J Radiat Biol 61:169-174, 1992.
88. Sugawara N, Ivanov K, Fishman-Lobell J, Ray B, Wu X, Haber J: DNA structure-dependent requirements for yeast RAD genes in gene conversion. Nature 373:84-86, 1995.
89. Billings P, St. Clair W, Owen A, Kennedy A: Potential intracellular target proteins of the anticarcinogenic Bowman-Birk protease inhibitor identified by affinity chromatography. Cancer Res 48:1798-1802, 1988.
90. Potempa J, Korzus E, Travis J: The serpin superfamily of proteinase inhibitors: Structure, function, and regulation. J Biol Chem 269:15957-15960, 1994.
91. 1-PI deficiency. J Clin Invest 81:1774-1780, 1988.
92. Perlmutter D, Joslin G, Nelson P, Schasteen C, Adams S, Fallon R: Endocytosis and degradation of α1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor. J Biol Chem 265:16713-16716, 1990.
93. Perlmutter D, Glover G, Rivetna M, Schasteen C, Fallon R: Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc Natl Acad Sci USA 87:3753-3757, 1990.
94. Zou Z, Anisowicz A, Hendrix M, et al: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526-529, 1994.
95. Billings P, Habres J: A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Proc Natl Acad Sci USA 89:3120-3124, 1991.
96. Carew J, Kennedy A: Identification of a proteolytic activity which responds to anticarcinogenic protease inhibitors in C3H/10T1/2 cells. Cancer Lett 49:153-163, 1990.
97. Yavelow J, Caggana M, Beck K: Proteases occurring in the cell membrane: A possible cell receptor for the Bowman-Birk type of protease inhibitors. Cancer Res 47:1598-1601, 1987.
98. Benedict C, Ren L, Clawson G: Nuclear multicatalytic proteinase a subunit RRC3: Differential size, tyrosine phosphorylation, and susceptibility to antisense oligonucleotide treatment. Biochemistry 34:9587-9598, 1995.
99. Cooper E, Stone J: Acute phase reactant proteins in cancer. Adv Cancer Res 30:1-44, 1979.
100. 1-antichymotrypsin by an immunohistochemical technique. Gann 73:742-747, 1982.
101. 1-antichymotrypsin into carcinoma cell nuclei of human stomach adenocarcinoma transplanted into nude mice. Cancer Res 46:3688-3691, 1986.
102. 1-antichymotrypsin. Cancer Res 46:6139-6142, 1986.
103. 1-antichymotrypsin on DNA synthesis in permeabilized human cells. Biochem Biophys Res Commun 144:409-414, 1987.
104. Horisberger M, Tacchini-Vonlanthen M: Ultrastructural localization of Bowman-Birk inhibitor on thin sections of glycine max (soybean) cv. Maple Arrow by the gold method. Histochemistry 77:313-321, 1983.
105. Kumatori A, Tanaka K, Inamura N, et al: Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci USA 87:7071-7075, 1990.
106. Kanayama H, Tanaka K, Aki M, et al: Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res 51:6677-6685, 1991.
107. Tokes Z, Clawson G: Proteolytic activity associated with the nuclear scaffold: The effect of self-digestion on lamins. J Biol Chem 264:15059-15065, 1989.
108. Seufert W, Futcher B, Jentsch S: Role of a ubiquilin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373:78-81, 1995.
109. Treier M, Staszewski L, Bohmann D: Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain. Cell 78:787-798, 1994.
110. Ciechanover A, DiGiuseppe J, Bercovich B, et al: Degradation of nuclear oncoproteins by the ubiquilin system in vitro. Proc Natl Acad Sci USA 88:139-143, 1991.
111. Rogers S, Well R, Rechsteiner M: Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science 234:364-369, 1986.
112. Cavagnaro J, Pierce D, Lucchesi J, Chae C: Association of a protease with polytene chromosomes of Drosophila melanogaster. J Cell Biol 87:415-419, 1980.
113. Carter D, Efiro P, Chae C: Chromatin-bound protease: [3H]Diisopropyl fluorophosphate labeling patterns of chromatin. Biochemistry 15:2603-2607, 1976.
114. Trapani J, Smyth M, Apostolidis V, Dawson M, Browne K: Granule serine proteases are normal nuclear constituents of natural killer cells. J Biol Chem 269:18359-18365, 1994.